Activation and Potentiation of Interferon-γ Signaling by 3,3′-Diindolylmethane in MCF-7 Breast Cancer Cells

2002, Antivir Ther, 7, 1, 10.1177/135965350200700101

10.1146/annurev.immunol.15.1.749

10.1093/carcin/bgh121

10.1093/carcin/19.9.1631

10.1016/S0196-0709(97)90012-0

10.1074/jbc.273.7.3838

10.1016/0167-5699(90)90114-O

10.1006/excr.1998.4296

10.1084/jem.20030390

10.1074/jbc.M100496200

1982, J Virol, 44, 393, 10.1128/JVI.44.1.393-400.1982

10.1126/science.2997918

10.1021/tx00026a007

1995, Anticancer Res, 15, 709

10.1016/S0006-2952(02)00856-0

10.1093/carcin/23.8.1297

10.1016/S1359-6101(01)00038-7

1993, Mol Cell Biol, 13, 3951, 10.1128/MCB.13.7.3951

1996, Obstet Gynecol Clin North Am, 23, 699

1996, J Biol Chem, 71, 10508

1997, Cell Biochem, 167, 169, 10.1023/A:1006854110122

2000, Adv Immunol, 74, 181

10.1007/s00432-003-0492-0

10.1016/S0006-2952(00)00307-5

10.1016/S0194-5998(98)70274-8

10.1016/0278-6915(83)90265-X

10.1016/0009-2797(84)90008-5

10.1021/tx010056m

10.1146/annurev.iy.06.040188.002043

1978, Cancer Res, 38, 1410

2003, Curr Opin Otolaryngol Head Neck Surg, 11, 433, 10.1097/00020840-200312000-00005

1995, Cancer Res, 55, 2135

1998, Cancer Biother Radiopharm, 13, 193, 10.1089/cbr.1998.13.193

10.1038/sj.onc.1208434

1999, Anticancer Res, 19, 1673